Your browser doesn't support javascript.
loading
Risk-Benefit Balance of Simultaneous Gastric Bypass or Sleeve Gastrectomy and Concomitant Cholecystectomy: A Comprehensive Nationwide Cohort of 289,627 Patients.
Marciniak, Camille; Lenne, Xavier; Bruandet, Amélie; Hamroun, Aghiles; Génin, Michaël; Baud, Grégory; Theis, Didier; Pattou, François; Caiazzo, Robert.
Affiliation
  • Marciniak C; General and Endocrine Surgery Department, Lille University Hospital CHU Lille, Lille, France.
  • Lenne X; Inserm, U1190 Translational research on diabetes (EGID), Lille University Univ.Lille, Lille, France.
  • Bruandet A; Medical Information Department, Lille University Hospital, Lille, France.
  • Hamroun A; Medical Information Department, Lille University Hospital, Lille, France.
  • Génin M; Public health, Epidemiology - UMR 1167 Ridage, Institut Pasteur de Lille, Univ Lille, Chu Lille, Lille, France.
  • Baud G; University of Lille, CHU Lille, ULR 2694 - METRICS: Health technology and medical practice assessment, F-59000 Lille, France.
  • Theis D; General and Endocrine Surgery Department, Lille University Hospital CHU Lille, Lille, France.
  • Pattou F; Inserm, U1190 Translational research on diabetes (EGID), Lille University Univ.Lille, Lille, France.
  • Caiazzo R; Medical Information Department, Lille University Hospital, Lille, France.
Ann Surg ; 278(5): 725-731, 2023 11 01.
Article in En | MEDLINE | ID: mdl-37476980
ABSTRACT

OBJECTIVE:

To assess the relevance of concomitant laparoscopic metabolic bariatric surgery (MBS) and cholecystectomy.

BACKGROUND:

Because of the massive weight loss it induces, MBS is associated with an increase in the frequency of gallstones. However, no consensus yet exists on the risk-to-benefit ratio of a concomitant cholecystectomy (CC) during MBS to prevent long-term biliary complications.

METHODS:

This nationwide retrospective cohort research was conducted in 2 parts using information from a national administrative database (PMSI). The 90-day morbidity of MBS with or without CC was first compared in a matched trial (propensity score). Second, we observed medium-term biliary complication following MBS when no CC had been performed during MBS up to 9 years after MBS (minimum 18 months).

RESULTS:

Between 2013 and 2020, 289,627 patients had a sleeve gastrectomy (SG 70%) or a gastric bypass (GBP 30%). The principal indications of CC were symptomatic cholelithiasis (79.5%) or acute cholecystitis (3.6%). Prophylactic CC occurred only in 15.5% of the cases. In our matched-group analysis, we included 9323 patients in each arm. The complication rate at day 90 after surgery was greater in the CC arm [odds ratio=1.3 (1.2-1.5), P <0.001], independently of the reason of the CC. At 18 months, there was a 0.1% risk of symptomatic gallstone migration and a 0.08% risk of biliary pancreatitis. At 9 years, 20.5±0.52% of patients underwent an interval cholecystectomy. The likelihood of interval cholecystectomy decreased from 5.4% per year to 1.7% per year after the first 18 months the whole cohort, risk at 18 months of symptomatic gallstone migration was 0.1%, of pancreatitis 0.08%, and of angiocholitis 0.1%.

CONCLUSION:

CC during SG and GBP should be avoided. In the case of asymptomatic gallstones after MBS, prophylactic cholecystectomy should not be recommended.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatitis / Obesity, Morbid / Gastric Bypass / Gallstones Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Year: 2023 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatitis / Obesity, Morbid / Gastric Bypass / Gallstones Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Year: 2023 Type: Article Affiliation country: France